United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
- PMID: 34399024
- DOI: 10.1111/nmo.14237
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
Abstract
Background: Gastroparesis is a condition characterized by epigastric symptoms and delayed gastric emptying (GE) rate in the absence of any mechanical obstruction. The condition is challenging in clinical practice by the lack of guidance concerning diagnosis and management of gastroparesis.
Methods: A Delphi consensus was undertaken by 40 experts from 19 European countries who conducted a literature summary and voting process on 89 statements. Quality of evidence was evaluated using grading of recommendations assessment, development, and evaluation criteria. Consensus (defined as ≥80% agreement) was reached for 25 statements.
Results: The European consensus defined gastroparesis as the presence of symptoms associated with delayed GE in the absence of mechanical obstruction. Nausea and vomiting were identified as cardinal symptoms, with often coexisting postprandial distress syndrome symptoms of dyspepsia. The true epidemiology of gastroparesis is not known in detail, but diabetes, gastric surgery, certain neurological and connective tissue diseases, and the use of certain drugs recognized as risk factors. While the panel agreed that severely impaired gastric motor function is present in these patients, there was no consensus on underlying pathophysiology. The panel agreed that an upper endoscopy and a GE test are required for diagnosis. Only dietary therapy, dopamine-2 antagonists and 5-HT4 receptor agonists were considered appropriate therapies, in addition to nutritional support in case of severe weight loss. No consensus was reached on the use of proton pump inhibitors, other classes of antiemetics or prokinetics, neuromodulators, complimentary, psychological, or more invasive therapies. Finally, there was consensus that gastroparesis adversely impacts on quality of life and healthcare costs and that the long-term prognosis of gastroparesis depends on the cause.
Conclusions and inferences: A multinational group of European experts summarized the current state of consensus on definition, symptom characteristics, pathophysiology, diagnosis, and management of gastroparesis.
Keywords: consensus; endoscopy; gastric emptying; gastroparesis; guideline; prokinetic.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.United European Gastroenterol J. 2021 Apr;9(3):287-306. doi: 10.1002/ueg2.12060. United European Gastroenterol J. 2021. PMID: 33939892 Free PMC article.
-
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia.United European Gastroenterol J. 2021 Apr;9(3):307-331. doi: 10.1002/ueg2.12061. United European Gastroenterol J. 2021. PMID: 33939891 Free PMC article.
-
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia.Neurogastroenterol Motil. 2021 Sep;33(9):e14238. doi: 10.1111/nmo.14238. Neurogastroenterol Motil. 2021. PMID: 34586707
-
Rome Foundation and international neurogastroenterology and motility societies' consensus on idiopathic gastroparesis.Lancet Gastroenterol Hepatol. 2025 Jan;10(1):68-81. doi: 10.1016/S2468-1253(24)00284-X. Lancet Gastroenterol Hepatol. 2025. PMID: 39674226
-
Emerging drugs for the treatment of gastroparesis.Expert Opin Emerg Drugs. 2014 Jun;19(2):261-79. doi: 10.1517/14728214.2014.899353. Epub 2014 Mar 26. Expert Opin Emerg Drugs. 2014. PMID: 24669936 Review.
Cited by
-
Guidelines, top-notch science & social media-Jump on the bandwagon.United European Gastroenterol J. 2022 Feb;10(1):12-14. doi: 10.1002/ueg2.12203. Epub 2022 Jan 28. United European Gastroenterol J. 2022. PMID: 35088535 Free PMC article. No abstract available.
-
Gastric sensorimotor function and its clinical measurement.Neurogastroenterol Motil. 2022 Dec;34(12):e14489. doi: 10.1111/nmo.14489. Epub 2022 Nov 13. Neurogastroenterol Motil. 2022. PMID: 36371709 Free PMC article. Review.
-
Pyloric Dysfunction: A Review of the Mechanisms, Diagnosis, and Treatment.Gut Liver. 2025 May 15;19(3):327-345. doi: 10.5009/gnl240421. Epub 2025 Mar 10. Gut Liver. 2025. PMID: 40058793 Free PMC article. Review.
-
Predicting Response to Neuromodulators or Prokinetics in Patients With Suspected Gastroparesis Using Machine Learning: The "BMI, Infectious Prodrome, Delayed GES, and No Diabetes" Model.Clin Transl Gastroenterol. 2024 Sep 1;15(9):e1. doi: 10.14309/ctg.0000000000000743. Clin Transl Gastroenterol. 2024. PMID: 39320959 Free PMC article.
-
Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect.Front Neurosci. 2022 Apr 26;16:831761. doi: 10.3389/fnins.2022.831761. eCollection 2022. Front Neurosci. 2022. PMID: 35557605 Free PMC article. Review.
References
REFERENCES
-
- Parkman HP, Camilleri M, Farrugia G, McCallum RW, Bharucha AE, Mayer EA, et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil. 2010;22(2):113-33.
-
- Tack J, Carbone F, Rotondo A. Gastroparesis. Curr Opin Gastroenterol. 2015;31(6):499-505.
-
- Tack J, Camilleri M. New developments in the treatment of gastroparesis and functional dyspepsia. Curr Opin Pharmacol. 2018;43:111-7.
-
- Stanghellini V, Tack J. Gastroparesis: separate entity or just a part of dyspepsia? Gut. 2014;63(12):1972-8.
-
- Wauters L, Dickman R, Drug V, Mulak A, Serra Pueyo J, Enck P, et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. UEG J. 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical